Results 71 to 80 of about 9,019 (158)

Telmisartan and Obesity

Internal Medicine, 2010
openaire   +3 more sources

Pharmacokinetic interactions between three SGLT2 inhibitors and telmisartan: A focus on empagliflozin, ertugliflozin, and henagliflozin. [PDF]

PLoS One
Zhou X, Deng Y, Guo C, Li Y, Fu Y, Wang Z, Dong Z.   +6 more
europepmc   +1 more source

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial. [PDF]

Drug Des Devel Ther
Youn JC, Kim ES, Park TH, Lee YS, Hong SJ, Hwang JY, Han JK, Son JW, Lee CJ, Choi JH, Kwon SU, Kim SY, Park HC, Choi SH.   +13 more
europepmc   +1 more source

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). [PDF]

Int J Nephrol Renovasc Dis
Jadhav U, Guha S, Mittal H, Barik C, Gillurkar CS, Gupta SK, Gupta M, Saklecha S, Jadhav M, Choudhari SY, Patil S, Bhushan S, A D, Barkate H.   +13 more
europepmc   +1 more source

Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production. [PDF]

J Immunother Cancer
Murray CE, Ontiveros CO, Wentworth J, Blinkiewicz P, Leung B, Bai H, Spicer N, Holtz A, Tanner C, Balasubramanian A, Li W, Dray E, Zhao W, Curiel TJ.   +13 more
europepmc   +1 more source

Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial. [PDF]

J Clin Hypertens (Greenwich)
Ahn HS, Ahn JC, Cho JM, Lim KH, Han SH, Cho YK, Kim KH, Hong SJ, Lee CJ, Na JO, Sung KC, Choi K, Kim SY, Kim DH, Lee HC, Ihm SH, Youn JC, Choi JY, Kim SH, Kim KI, Sung JH, Pyun WB, Kim WS, Cho JS, Lee Y, Her SH, Cho EJ, Lee EM, Lee HY, Yoon YW, Lee JH, Kim W, Rhee SJ, Shin J.   +33 more
europepmc   +1 more source

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg). [PDF]

Transl Clin Pharmacol
Chang K, Won H, Lee T, Kwon S, Lee SH, Cho JY, Yu KS.   +6 more
europepmc   +1 more source

Comparative radioprotective effects of ascorbic acid and telmisartan, alone and in combination, on gamma-irradiated mandibular bone: an experimental rat study. [PDF]

Saudi Dent J
Abdel-Aziz LM, Esmail RM, Abdelfatah H, Sayed AI.   +3 more
europepmc   +1 more source

Angiotensin II type 1 and type 2 receptors modulate TWIK1 channel expression and pain sensitivity in a rat model of neuropathic pain. [PDF]

Front Pharmacol
Peralta ED, Stable García Y, Soria SV, Benitez SG, Acosta CG.   +4 more
europepmc   +1 more source

Neuroprotective effects of telmisartan in a harmaline-induced model of essential tremor: modulation of the renin-angiotensin system and inflammatory pathways. [PDF]

Front Pharmacol
Farrag SM, Emam AM, Kamel AS, Saad MA, Kortam MA, Sayed NH, Fathy N.   +6 more
europepmc   +1 more source